For example, in estrogen-responsive breast cancer cells, elevated SphK1 is associated with endocrine resistance [24, 28], and the spatial organization of SphK1 in ER positive breast tumors is aligned with the prognostic outcome [56]. This evidence concerns the gene SPHK1 and breast carcinoma.